2007
DOI: 10.1016/s0168-8278(07)61818-2
|View full text |Cite
|
Sign up to set email alerts
|

[220] Intravenous Albumin Is Not Necessary in Cirrhotic Patients With Spontaneous Bacterial Peritonitis and Low-Risk of Mortality

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
6
0

Year Published

2008
2008
2019
2019

Publication Types

Select...
3
3
1

Relationship

0
7

Authors

Journals

citations
Cited by 14 publications
(6 citation statements)
references
References 0 publications
0
6
0
Order By: Relevance
“…This is based on a non–placebo‐controlled study in patients with SBP, in which the intravenous administration of albumin decreased the risk of HRS by 66% compared with antibiotic treatment alone 82. However, the benefit of albumin is observed mainly in patients with SCr greater than 1.0, urea greater than 30 mg/dL, or a serum bilirubin greater than 4 mg/dL,82–84 that is, patients who already have some degree of renal dysfunction at the time of the diagnosis of SBP.…”
Section: Preventionmentioning
confidence: 99%
“…This is based on a non–placebo‐controlled study in patients with SBP, in which the intravenous administration of albumin decreased the risk of HRS by 66% compared with antibiotic treatment alone 82. However, the benefit of albumin is observed mainly in patients with SCr greater than 1.0, urea greater than 30 mg/dL, or a serum bilirubin greater than 4 mg/dL,82–84 that is, patients who already have some degree of renal dysfunction at the time of the diagnosis of SBP.…”
Section: Preventionmentioning
confidence: 99%
“…Renal impairment occurs in < 10% of patients when serum bilirubin is < 4 mg/dL and serum creatinine is < 1 mg/ dL. 104,105 As albumin is an expensive blood product with associated risks, its use should be limited to high-risk patients (bilirubin > 4 mg/dL, creatinine > 1 mg/dL) with SBP.…”
Section: Treatmentmentioning
confidence: 99%
“…In patients with cirrhosis, an open‐label unblinded randomized clinical trial (RCT) in patients with SBP (without shock) treated with cefotaxime showed that the intravenous administration of a 20% albumin solution reduced the incidence of renal failure and decreased mortality rates from 29% to 10% 41. This effect was not observed in patients with a low risk of mortality (total bilirubin <4 mg/dL and creatinine <1 mg/dL) 53. A recent small unblinded RCT suggested that a 20% albumin solution improved systemic hemodynamics better than a 6% hydroxyethylstarch solution in SBP 54.…”
Section: Management Of Severe Sepsis and Septic Shock In Patients Witmentioning
confidence: 99%